Harnessing Longitudinal Patient Data

Culmination Bio is focused on addressing a significant issue in drug and diagnostics development: the lack of access to comprehensive longitudinal patient data. The organization has amassed an extensive data platform that includes over 40 years of de-identified electronic health records and biospecimen data, making it one of the largest patient data repositories available. This platform allows pharmaceutical companies and biotech firms to obtain the critical datasets they need to expedite their R&D processes, thereby enhancing the discovery and validation of new tests and therapies. By leveraging these vast data assets, Culmination Bio aims to bridge the gap between health systems and the requirements of the industry for innovative healthcare solutions.